in 502 subjects, and death was ascertained in 56 participants. Thirty deaths were attributed to coronary and cerebrovascular disease. Cumulative 22-year evaluation of participants in the age bracket 45-74 years revealed coronary mortality to be high, with 7.6 per 1000 person-years in men and 3.8 in women. Data used from 1754 identical subjects (median age 46 years initially), and examined in two periods 12 years apart, indicated an increase in the prevalence of MetS by 1.3% per aging of 1 year. Analysis across geographic regions showed a rise in the prevalence in the Mediterranean region, already having highest prevalence along with thr Southeast Anatolia, while the prevalence declined in the Marmara region and persisted to be thr lowest in the Aegean region. Conclusion: The prevalence of MetS in Turkish adults aged 40 years or over, currently standing at 53%, shows significant differences across geographic regions, being highest in the two southern regions and lowest in the Aegean region. 
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PATIENTS AND THE METHOD
Surveyed dwelling units, and participants monitored
Five regions of Turkey screened on even years in the TEKHARF study were surveyed again following a certain route (excluding Kütahya, Güre, Kaynaşlı, Zonguldak but including three quarters of Istanbul) in the beginning of fall 2012. Van Kars, Karapınar (HAG) and Diyarbakır cohorts (MA) were screened by two independent surveyors, while the main cohort was followed up by two teams. Screening of Içme (Elazığ) participants were postponed. The cohort to be surveyed consisted of a total of 1527 participants which constituted nearly half of the survived TEKHARF cohort [4] which will be followed up all over the country. Total follow-up period was calculated as the sum of the individual follow-up periods of the participants examined with reliable information about their deaths or survivals. Loss to follow-up was defined as to be unexamined for at least for 8 years. Indeed, according to our experiences, the possibility of a participant to return for a follow-up visit after more than 8 years is very low. In the analysis of long-term regional follow-up periods, only the time to the last examination date of the participant was regarded as the follow-up period. In participants who were lost to follow up, the shortest follow-up period recorded at baseline was ruled out.
Information acquisition method
During the study survey, information was obtained directly from anamnesis, physical (PE) , and electrocardiographic examinations. Information about the current health state of the patients who weren't examined was retrieved by phone contacts with themselves, close relatives, and neighbours. The data acquired were recorded, and these participants were followed up for 12 months or for shorter periods instead of 24 months.
Determination of death events, and some definitions
Information about the approximate date, place, type, and cause of the death event was gathered as far as possible. Death event occurring within 24 hours of the symptom onset was considered as sudden death, and if some other explanation of the death event could not be found, then it was attributed to cardiac causes. Information about the cause of death was gathered from the first degree relatives of the deceased and/or from the personnel of the primary health care center. Cause of death was also determined in consideration of available preexisting clinical, and laboratory findings detected in biennial survey studies. Coronary mortality involved deaths from coronary heart failure, and a fatal coronary event.
Proportion between our adult population, and the sampling size Currently survived TEKHARF participants not lost to follow-up consisted of 3000 individuals, and based on the Turkish Statistical Institute (TÜİK) data on Turkish population aged 40 and over (total n, 24.4 million; 11.9 million male, and 12.5 million female individuals) , our sampling represented 12.3/100.000 of the country's population in this age bracket.
Evaluation of the metabolic syndrome prevalence
Metabolik syndrome was defined based on, National Heart, Lung, Blood Institute/American Heart Association's criteria of abdominal obesity in men with application of ≥ 95 cm modification by TEKHARF. Peculiar characteristics of seven geographic regions were taken into consideration. For the comparison of prevalences of MetS, the same study participants examined during both 1997-2000, and 2009-2011 surveys which constituted most of the cohort were used. The impact of 12 years passed on aging was not actually ruled out, but their role was taken into consideration.
RESULTS
A. Follow-up data of the last survey
More than half (n= 796: 52 %) participants from a cohort of 1527 subjects (incl. 34 new individuals participating from Istanbul) were examined, and 56 (3.7 %) cases of death were identified. A little more than one third (n=280) of the participants undergoing medical examinations were not screened during 2010 survey. Information was gathered from only one third of (502 individuals) the cohort, and 173 (11.3 %) were lost to follow-up. Total follow-up period reached to 2700 person-years. Fifty six cases of death corresponded to 20.7 cases per 1000 person-years during the whole follow-up period. Mean age at death was 68.0±15.7 years. A total of 54 deaths were identified (22 women, 34 men). Death events were related to coronary artery disease (n=24), cerebrovascular event (n=6; most of them are of embolic type), aortic stenosis (n=1), bilateral bundle branch fibrosis (n=1), renal failure (n=4), cancer (n=12) , chronic obstructive pulmonary disease (n=2), Alzheimer's disease (n=1), diabetes (n=1), and indeterminate causes (n=3). In this survey period, coronary annual mortality was found to be 8.9/1000 participants.
B. Twenty years of the follow-up
analysis.
Total mortality
Distribution of 742 death events occurred in all TEKHARF cohorts in specified periods, and mortality rates per 1000 person-years are presented in Table  1 
All-cause, and coronary mortality in the
45-74 age bracket
All-cause, and coronary mortality rates in the 45-74 age bracket are explained based on distribution of gender, and the followup periods ( Table 2 ). In this age group, during 21.5 years of follow-up annually 13.3 deaths per 1000 individuals (16.9 in men, and 9.8 in women) were recorded. Coronary mortality rates in this age range were 7.6, and 3.8 deaths per 1000 individuals as estimated from the start of the survey. At the end of the survey number of cohorts suitable for further screening, and a new cohort enrolled from Istanbul.
Data stratified according to the enrollment period, and geographic regions of the participants of the cohort whom we had personal medical information, and physically examined at the end of the year 2012 who are also suitable for further follow up are explained in Table 3 .
Starting from the finding that mean rates of mortality, and lost to followup among TEKHARF cohort participants during two years of the survey were 3, and 5 % respectively [4] we think that time has come to enroll new participants in the study. Based on the justification that number of cohort participants droppe to a total of 2703 individuals, 34 subjects from (mostly needed)
Istanbul were additionally enrolled in the 2012 survey. It will be appropriate to enroll a new group of 180 participants in the 2013 survey from Marmara Region inhabitants. 
TEKHARF: Turkish Adult Risk Factor Study survey
Changes in the prevalence of MetS in the first, and the last survey study periods
Distribution of MetS prevalence according to age groups among1750 participants examined in each of the two survey study periods separated by 12 years apart is presented in Table 4 . In the beginning median (interquartile range) age was 46 (37;56) years, while in the last survey it was 57.5 (49; 68) years, and prevalence of MetS was found to be 51.8 percent. This increase in the abovementioned middle age group corresponds to an annual increase of 0.013. The current prevalence of metabolic syndrome in the entire cohort of 3800 participants was estimated as, 49.9 %, while it was 45.1, and 54.5 % among male, and female populationsw, respectively, Distribution of prevalence rates based on age groups of male, and female participants is shown in Figure 1 , while their distribution according to the geographic regions of the country is seen in Figure 2 . Incidence of MetS increases up to 60-69 years of age, and then it decreases in advanced age (more conspicuous in men) in a ratio of one tenth. However in the first survey period, ≥ 70 age group accounts for 4 % of the MetS prevalence of the whole cohort, while in the last survey its share increases to 24 percent. Overall prevalence is the lowest in the Aegean Region, but it is higher in the Southern Anatolia, and the Black Sea Region. If one considers only the cohort of ≥ 40 years of age, and compare the first, and the last survey periods, overall prevalence remained stable (54 % vs 52.9 %). However in the Mediterranean Region its prevalence notably rised from 56.1 % to 63.6 percent. Its prevalence regressed only in the Marmara Region. 
DISCUSSION
Fifty six death events detected in the last survey study which included half of TEKHARF study population, represent the highest mortality rates reported so far, and a 1.4 -year shorter mean age at death was noteworthy. In all cohort, death events recorded in the 45-74 age bracket displayed an increasing trend to 16.9, and 9.8 deaths per 1000 person-years in parallel with the whole survey. Coronary mortality appears to be in a similar trend with 6.66 per 1000 person-years. Our findings were remarkable provided that the same definitions are used in both surveys. For example, annual prevalence of MetS among individuals participated in both surveys increased at a rate of 1.3 % within the previous 12 years, and its relatively lower levels sustained in the Aegean Region. Besides, its prevalence increased in the Mediterranean Region, but regressed in the Marmara Region Based on a total number of 102 death events detected in 2011, and 2012 survey studies, ( when distribution of age is considered, and coefficient of 7000 is applied) annual number of 350.000 death events among our population aged ≥ 40 years can be presumed. This estimate appears to be 10 % higher than that issued by the Turkish Institute of Statistics (TUIK) (321.000 for the year 2010) among Turkish population aged ≥ 40 years [4] .
Coronary mortality rates apparently increased in parallel with the increasing tendency in the overall mortality rates. However certainly a trend concerning coronary mortality rates can not be deduced only from data obtained from two years of survey.
Variations in the prevalence of MetS
While evaluating variations in the prevalence of MetS in our people, it should be considered that our sampling size included lesser number of individuals younger than 40 years, and its prevalence gradually, and notably regressed especially in men from 70 years of age on. Based on this justification, we must state that we excluded participants younger than 40 years of age from both survey studies or analyzed the state of the same participants in both survey periods. In conclusion, we observed that MetS was present in half of our citizens in their middle, and advanced ages which represented a moderate increase in the prevalence within the previous ten years. We also observed that this increase was prominent especially in the Mediterranean Region, while it regressed in the Marmara Region. In another investigation of ours conducted nine years ago where unmodified ATP-III criteria were applied, the lowest prevalence was reported for the Aegean, and Eastern Anatolian Regions [7] . Though the source of regional differences can not be certainly determined, mostly malnutritional abdominal obesity can be predicted as a weighted determinative factor. A large scale correlation between distribution of MetS prevalence, and incidence of CHD [3] can be stated.
Limitations of the study
The main objectives of this study survey is to assess changes in the study cohort, and share the progressive variations in some fundamental data with our colleagues without indulging in analytical processes in depth. So being a link of a chain of traditional article series, this survey study has certainly some limitations.
In conclusion, it will be appropriate to indicate that in our nationwide TEKHARF survey we have observed a slight increase in overall, and coronary mortality rates within the last 2 years irrespective of aging. The incidence of MetS among our citizens aged 40 years or older is 53 %, but it increases moderately within the last 10 years with varying frequencies among geographic regions. Overall prevalence of Mets in southern Anatolia, and Black Sea regions is higher, while it is persistemtly lower in the Aegean Region We have also observed higher prevalence rates for MetS in the Mediterranean Region, but its prevalence regressed in the Marmara Region.
